Watchlist Price Alert

TransCode Therapeutics In... (RNAZ)

NASDAQ: RNAZ · Real-Time Price · USD

8.08

-1.63 (-16.77%)

At close: May 15, 2025, 11:02 AM

TransCode Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-16.75M	-18.55M	-17.56M	-6.84M	-2.34M	-607.21K	-453.44K
Depreciation & Amortization	534.86K	516.75K	98.61K	42.47K	n/a	n/a	n/a
Stock-Based Compensation	1.7M	1.04M	395.33K	186K	45.44K	1.4K	22.38K
Other Working Capital	n/a	-146.27K	-535.2K	-1.85M	118.51K	50.04K	24.94K
Other Non-Cash Items	1.53M	n/a	-890.95K	39.47K	1.5M	102.01K	106.55K
Deferred Income Tax	n/a	n/a	890.95K	876.19K	n/a	n/a	n/a
Change in Working Capital	-343.12K	-1.08M	1.31M	432.39K	309.76K	-4.7K	24.94K
Operating Cash Flow	-13.34M	-18.07M	-15.76M	-5.27M	-492.97K	-508.51K	-299.57K
Capital Expenditures	n/a	-35.61K	-100.92K	-254.82K	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	3K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-21.76K	n/a	-100.92M	3.00	n/a	n/a	n/a
Investing Cash Flow	-21.76K	-35.61K	-100.92K	-251.82K	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	1.19M	500K	550K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-30.6K	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	16.43M	n/a	5.99K	-818.55K	-73.48K	n/a	-37.57K
Financial Cash Flow	16.4M	15.91M	5.99K	25.52M	1.12M	500K	512.43K
Net Cash Flow	3.04M	-2.2M	-15.86M	20M	623.54K	-8.51K	212.86K
Free Cash Flow	-13.34M	-18.11M	-15.86M	-5.52M	-492.97K	-508.51K	-299.57K